Early research (Phase 1)Study completedNCT00390338What this trial is testingVaccine Therapy in Treating Patients With Stage III or Stage IV MelanomaWho this might be right forMelanoma (Skin) Pawel Kalinski 22
Testing effectiveness (Phase 2)UnknownNCT00002817What this trial is testingVaccine Therapy in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 30
Testing effectiveness (Phase 2)Study completedNCT00866840What this trial is testingRiluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by SurgeryWho this might be right forMelanoma (Skin) Rutgers, The State University of New Jersey 13
Early research (Phase 1)Ended earlyNCT00002947What this trial is testingIndium In 111 Pentetreotide in Treating Patients With Refractory CancerWho this might be right forBrain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more Yale University 35
Testing effectiveness (Phase 2)Ended earlyNCT00550654What this trial is testingConformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the BrainWho this might be right forKidney CancerMelanoma (Skin)Metastatic Cancer+3 more National Institutes of Health Clinical Center (CC) 1
Testing effectiveness (Phase 2)Study completedNCT00071981What this trial is testingVaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) Eastern Cooperative Oncology Group 175
Testing effectiveness (Phase 2)Study completedNCT00255762What this trial is testingCarboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By SurgeryWho this might be right forRecurrent MelanomaStage IV Melanoma National Cancer Institute (NCI) 47
Testing effectiveness (Phase 2)Study completedNCT00027586What this trial is testingImatinib Mesylate in Treating Patients With Metastatic MelanomaWho this might be right forMelanomaSkin Neoplasms M.D. Anderson Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT00096083What this trial is testingHepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerWho this might be right forCancer Delcath Systems Inc. 56
Testing effectiveness (Phase 2)Study completedNCT01835145What this trial is testingCabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by SurgeryWho this might be right forRecurrent Uveal MelanomaStage III Uveal Melanoma AJCC v7Stage IIIA Uveal Melanoma AJCC v7+3 more National Cancer Institute (NCI) 47
Testing effectiveness (Phase 2)Ended earlyNCT00087373What this trial is testingVaccine Therapy in Treating Patients With Metastatic MelanomaWho this might be right forRecurrent MelanomaStage IV Melanoma National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Study completedNCT00005875What this trial is testingNitrocamptothecin in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) Astex Pharmaceuticals, Inc.
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Large-scale testing (Phase 3)Study completedNCT00324727What this trial is testingHepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to MelanomaWho this might be right forIntraocular MelanomaMelanoma (Skin)Metastatic Cancer Delcath Systems Inc. 93
Early research (Phase 1)Study completedNCT01904123What this trial is testingSTAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the BrainWho this might be right forMetastatic Malignant Neoplasm in the BrainMetastatic MelanomaRecurrent Brain Neoplasm+2 more M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Ended earlyNCT03993379What this trial is testingPROCLAIM: CX-072-002: Study of PD-L1 Probody Therapeutic CX-072 in Combination With Other Anticancer Therapy in Adults With Solid TumorsWho this might be right forSolid TumorUnresectable or Metastatic Melanoma CytomX Therapeutics 3
Early research (Phase 1)Looking for participantsNCT05098210What this trial is testingPersonalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Cutaneous Melanoma+22 more Fred Hutchinson Cancer Center 28
Not applicableWithdrawnNCT02507076What this trial is testingIsolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or SarcomaWho this might be right forBasal Cell Carcinoma of the SkinEccrine Carcinoma of the SkinRecurrent Adult Soft Tissue Sarcoma+8 more Albert Einstein College of Medicine
Testing effectiveness (Phase 2)Study completedNCT00002786What this trial is testingBiological Therapy in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Ended earlyNCT04768881What this trial is testingSafety and Efficacy of Selinexor in Combination With Pembrolizumab in Recurrent Advanced MelanomaWho this might be right forLocally Advanced Unresectable or Metastatic Melanoma Karyopharm Therapeutics Inc 15